{"cluster": 0, "subcluster": 10, "abstract_summ": "Emerging evidence supports recently acquired anosmia (complete loss of smell) and hyposmia (partial loss of smell) as symptoms of COVID-19, but studies of olfactory dysfunction show a wide range of prevalence, from 5% to 98%.RESULTS: i) Among a subset of 55 patients consulting for primarily loss of smell, we found that 51 (92.7%) had a COVID-19 positive test (median viral load of 28.8 cycle threshold).Only twelve out of the patients without olfactory loss tested positive, resulting in a frequency of 64.7% for the symptom sudden smell loss in COVID-19 patients.OBJECTIVES: To determine the frequency of SARS-CoV-2 positive samples in a subset of patients consulting for primarily isolated acute (<7 days) loss of smell and to assess the diagnostic accuracy of olfactory/gustatory dysfunction for COVID-19 diagnosis in the overall population tested for COVID-19 in the same period.Only 12 out of the patients without olfactory loss tested positive, resulting in a frequency of 64.7% for the symptom \"sudden smell loss\" in COVID-19 patients.", "title_summ": "Predictive Value of Sudden Olfactory Loss in the Diagnosis of COVID-19.Predictive value of sudden olfactory loss in the diagnosis of COVID-19Objective sensory testing methods reveal a higher prevalence of olfactory loss in COVID-19 positive patients compared to subjective methods: A systematic review and meta-analysisSelf-reported loss of smell without nasal obstruction to identify COVID-19.The multicenter CORANOSMIA cohort studyTaste and Smell Impairment in COVID-19: An AAO-HNS Anosmia Reporting Tool-Based Comparative StudyOlfactory dysfunction from acute upper respiratory infections: relationship to season of onsetSmell and taste dysfunctions in COVID-19 are associated with younger age in ambulatory settings - a multicenter cross-sectional study.", "title_abstract_phrases": "RESULTS: i) Among a subset of 55 patients consulting for primarily loss of smell, we found that 51 (92.7%) had a COVID-19 positive test (median viral load of 28.8 cycle threshold).Emerging evidence supports recently acquired anosmia (complete loss of smell) and hyposmia (partial loss of smell) as symptoms of COVID-19, but studies of olfactory dysfunction show a wide range of prevalence, from 5% to 98%.Only twelve out of the patients without olfactory loss tested positive, resulting in a frequency of 64.7% for the symptom sudden smell loss in COVID-19 patients.The multicenter CORANOSMIA cohort studyOBJECTIVES: To determine the frequency of SARS-CoV-2 positive samples in a subset of patients consulting for primarily isolated acute (<7 days) loss of smell and to assess the diagnostic accuracy of olfactory/gustatory dysfunction for COVID-19 diagnosis in the overall population tested for COVID-19 in the same period.Only 12 out of the patients without olfactory loss tested positive, resulting in a frequency of 64.7% for the symptom \"sudden smell loss\" in COVID-19 patients."}